# Iacopo Olivotto

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/iacopo-olivotto/

## Facts

| Field | Value |
| --- | --- |
| Citations | 40,602 |
| Field | Cardiomyopathy and Myosin Studies |
| h-index | 93 |
| i10-index | 372 |
| Last Known Institution | Brigham and Women's Hospital |
| OpenAlex ID | https://openalex.org/A5029153489 |
| ORCID iD | https://orcid.org/0000-0003-1751-9266 |
| Works | 764 |

## Researcher papers

- [2023 ESC Guidelines for the management of cardiomyopathies](https://scholariq.org/papers/2023-esc-guidelines-for-the-management-of-cardiomyopathies/)
- [Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/mavacamten-for-treatment-of-symptomatic-obstructive-hypertrophic-cardiomyopathy/)
- [Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy](https://scholariq.org/papers/prognostic-value-of-quantitative-contrast-enhanced-cardiovascular-magnetic/)
- [Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy](https://scholariq.org/papers/genotype-and-lifetime-burden-of-disease-in-hypertrophic-cardiomyopathy/)
- [Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic Cardiomyopathy](https://scholariq.org/papers/long-term-effects-of-surgical-septal-myectomy-on-survival-in-patients-with/)
- [Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study](https://scholariq.org/papers/oral-pharmacological-chaperone-migalastat-compared-with-enzyme-replacement/)
- [Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry](https://scholariq.org/papers/distinct-subgroups-in-hypertrophic-cardiomyopathy-in-the-nhlbi-hcm-registry/)
- [Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis](https://scholariq.org/papers/evidence-based-guideline-for-the-diagnosis-and-management-of-eosinophilic/)
- [A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy](https://scholariq.org/papers/a-validated-model-for-sudden-cardiac-death-risk-prediction-in-pediatric/)
- [An Expert Consensus Document on the Management of Cardiovascular Manifestations of Fabry Disease](https://scholariq.org/papers/an-expert-consensus-document-on-the-management-of-cardiovascular-manifestations/)
- [Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction](https://scholariq.org/papers/hypertrophic-cardiomyopathy-with-left-ventricular-systolic-dysfunction/)
- [Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy](https://scholariq.org/papers/clinical-characteristics-and-outcomes-in-childhood-onset-hypertrophic/)

## Researcher topics

- [Cardiomyopathy and Myosin Studies](https://scholariq.org/topics/cardiomyopathy-and-myosin-studies/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Cardiovascular Effects of Exercise](https://scholariq.org/topics/cardiovascular-effects-of-exercise/)
- [Cardiac electrophysiology and arrhythmias](https://scholariq.org/topics/cardiac-electrophysiology-and-arrhythmias/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)

## Researcher university

- [Brigham and Women's Hospital](https://scholariq.org/institutions/brigham-and-women-s-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.